Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis

被引:1
|
作者
Bonnett, Shilah [1 ]
Jee, Jo-Ann [1 ]
Chettiar, Somsundaram [1 ]
Ovechkina, Yulia [1 ]
Korkegian, Aaron [1 ]
Greve, Eric [2 ]
Odingo, Joshua [1 ]
Parish, Tanya [1 ,2 ]
机构
[1] TB Discovery Res Infect Dis Res Inst, Seattle, WA 98102 USA
[2] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98105 USA
来源
MICROBIOLOGY SPECTRUM | 2023年 / 11卷 / 01期
基金
美国国家卫生研究院;
关键词
antitubercular; drug discovery; antibiotic; protein secretion; bactericidal activity; tuberculosis; DRUGS;
D O I
10.1128/spectrum.04974-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mycobacterium tuberculosis, the causative agent of tuberculosis, is a serious global health problem requiring the development of new therapeutics. We previously ran a high-throughput screen and identified a series of compounds with antitubercular activity. We identified an amino-benzothiazole scaffold from a whole-cell screen against recombinant Mycobacterium tuberculosis under expressing the essential signal peptidase LepB. The seed molecule had 2-fold higher activity against the LepB hypomorph. Through a combination of purchase and chemical synthesis, we explored the structure-activity relationship for this series; 34 analogs were tested for antitubercular activity and for cytotoxicity against eukaryotic cells. We identified molecules with improved potency and reduced cytotoxicity. However, molecules did not appear to target LepB directly and did not inhibit protein secretion. Key compounds showed good permeability, low protein binding, and lack of CYP inhibition, but metabolic stability was poor with short half-lives. The seed molecule showed good bactericidal activity against both replicating and nonreplicating bacteria, as well as potency against intracellular M. tuberculosis in murine macrophages. Overall, the microbiological properties of the series are attractive if metabolic stability can be improved, and identification of the target could assist in the development of this series.IMPORTANCE Mycobacterium tuberculosis, the causative agent of tuberculosis, is a serious global health problem requiring the development of new therapeutics. We previously ran a high-throughput screen and identified a series of compounds with antitubercular activity. In this paper, we test analogs of our hit molecules for activity against M. tuberculosis, as well as for activity against eukaryotic cells. We identified molecules with improved selectivity. Our molecules killed both replicating and nonreplicating bacteria but did not work by targeting protein secretion.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis
    Early, Julie
    Ollinger, Juliane
    Darby, Crystal
    Alling, Torey
    Mullen, Steven
    Casey, Allen
    Gold, Ben
    Ochoada, Jason
    Wiernicki, Todd
    Masquelin, Thierry
    Nathan, Carl
    Hipskind, Philip A.
    Parish, Tanya
    ACS INFECTIOUS DISEASES, 2019, 5 (02): : 272 - 280
  • [2] Plakinamine P, A Steroidal Alkaloid with Bactericidal Activity against Mycobacterium tuberculosis
    Felix, Carolina Rodrigues
    Roberts, Jill C.
    Winder, Priscilla L.
    Gupta, Rashmi
    Diaz, M. Cristina
    Pomponi, Shirley A.
    Wright, Amy E.
    Rohde, Kyle H.
    MARINE DRUGS, 2019, 17 (12)
  • [3] IS PYRAZINAMIDE BACTERICIDAL AGAINST MYCOBACTERIUM-TUBERCULOSIS
    HEIFETS, LB
    LINDHOLMLEVY, PJ
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (01): : 250 - 252
  • [4] In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex
    Rao, M.
    Sood, R.
    Malhotra, S.
    Fatma, T.
    Upadhyay, D. J.
    Rattan, A.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (02) : 144 - 150
  • [5] BACTERICIDAL ACTIVITY INVITRO OF VARIOUS RIFAMYCINS AGAINST MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-TUBERCULOSIS
    HEIFETS, LB
    LINDHOLMLEVY, PJ
    FLORY, MA
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03): : 626 - 630
  • [6] Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model
    Gupta, Shashank
    Tyagi, Sandeep
    Bishai, William R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 673 - 676
  • [7] Synthetic Calanolides with Bactericidal Activity against Replicating and Non replicating Mycobacterium tuberculosis
    Zheng, Purong
    Somersan-Karakaya, Selin
    Lu, Shichao
    Roberts, Julia
    Pingle, Maneesh
    Warrier, Thulasi
    Little, David
    Guo, Xiaoyong
    Brickner, Steven J.
    Nathan, Carl F.
    Gold, Ben
    Liu, Gang
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (09) : 3755 - 3772
  • [8] COMPARISON OF BACTERIOSTATIC AND BACTERICIDAL ACTIVITY OF ISONIAZID AND ETHIONAMIDE AGAINST MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-TUBERCULOSIS
    HEIFETS, LB
    LINDHOLMLEVY, PJ
    FLORY, M
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (02): : 268 - 270
  • [9] BACTERIOSTATIC AND BACTERICIDAL ACTIVITY OF CIPROFLOXACIN AND OFLOXACIN AGAINST MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-AVIUM COMPLEX
    HEIFETS, LB
    LINDHOLMLEVY, PJ
    TUBERCLE, 1987, 68 (04): : 267 - 276
  • [10] 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis
    Odingo, Joshua O.
    Early, Julie, V
    Smith, Jake
    Johnson, James
    Bailey, Mai A.
    Files, Megan
    Guzman, Junitta
    Ollinger, Juliane
    Korkegian, Aaron
    Kumar, Anuradha
    Ovechkina, Yulia
    Parish, Tanya
    DRUG DEVELOPMENT RESEARCH, 2019, 80 (05) : 566 - 572